Trial Profile
A phase I, open-label, single-dose, randomized, cross-over study of cenicriviroc (CVC) and tenofovir (TDF) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Aug 2011
Price :
$35
*
At a glance
- Drugs Cenicriviroc (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 20 Jul 2011 New trial record